Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the American Heart Association|October 18, 2023
Age-Stratified Prevalence and Relative Prognostic Significance of Traditional Atherosclerotic Risk Factors: A Report from the Nationwide Registry of Percutaneous Coronary Interventions in JapanKenji Kanenawa, Kyohei Yamaji, Shun Kohsaka, et al.
Circulation. Cardiovascular Interventions|February 5, 2021
Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled TrialKenji Kanenawa, Kyohei Yamaji, Hiroaki Tashiro, et al.
Frontiers in Cardiovascular Medicine|May 25, 2026
Impact of public assistance on long-term outcomes after hospitalization for acute heart failureTakashi Morinaga, Masahiro Natsuaki, Akihiro Isotani, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 29, 2026
Changes in Natriuretic Peptide Levels and Cardiac Structure in Patients Treated With VericiguatKenji Kanenawa, Kenji Ando, Takahito Nasu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 1, 2021
Clinical Outcomes After Percutaneous Coronary Intervention in Patients With CancerKenji Kanenawa, Kyohei Yamaji, Takashi Morinaga, et al.
The American Journal of Cardiology|March 5, 2021
Frailty and Bleeding After Percutaneous Coronary InterventionKenji Kanenawa, Kyohei Yamaji, Hiroaki Tashiro, et al.
ESC Heart Failure|February 6, 2021
The impact of frailty according to Clinical Frailty Scale on clinical outcome in patients with heart failureKenji Kanenawa, Akihiro Isotani, Kyohei Yamaji, et al.
ESC Heart Failure|January 20, 2025
The efficacy and safety of sodium-glucose cotransporter 2 inhibitors in patients aged over 80 years with heart failureKenji Nakano, Kenji Kanenawa, Akihiro Isotani, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 18, 2026
Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes - Prespecified Subgroup Analysis of the STOPDAPT-3 TrialKenji Kanenawa, Ko Yamamoto, Takenori Domei, et al.
Journal of the American Heart Association|October 22, 2024
Serial Optical Coherence Tomography Assessment of Coronary Atherosclerosis and Long-Term Clinical OutcomesKyohei Yamaji, Kenji Kanenawa, Toru Morofuji, et al.
Pageof 2